Scientific Reports · Nov 19, 2026
Milk and milk substitute consumption and hepatocellular carcinoma risk: the mediating role of metabolic dysfunction-associated steatotic liver disease
By Akhtar S, Almohaid S
Hepatocellular carcinoma (HCC) accounts for approximately 75% of primary liver cancers. Evidence on HCC risk factors in Middle Eastern countries, including Kuwait, remains limited. We previously reported that heavy alcohol consumption, metabolic dysfunction-associated steatotic liver disease (MASLD), and high consumption of milk and milk substitute were significant risk factors for HCC. This study examined the mediating role of MASLD in the association between milk and milk substitute consumption and HCC risk. Fifty-three histopathologically confirmed HCC cases were identified from the Kuwait Cancer Control Center Registry, and 196 controls (1:4 ratio) were recruited from medical and surgical outpatient clinics at six public hospitals. Data were collected through face-to-face interviews using a standardized questionnaire. Causal mediation analysis within the counterfactual framework was conducted to estimate the marginal total effect (MTE), natural direct effect (NDE), and natural indirect effect (NIE) of milk and milk substitute consumption on HCC risk mediated through MASLD. Effects were reported as odds ratios (ORs) with 95% confidence intervals (CIs). A higher proportion of HCC cases were aged ≥ 60 years compared with controls (79.2% vs. 45.9%). The milk and milk substitute consumption showed significant MTE (ORMTE = 5.97; 95% CI 1.69, 21.12; p = 0.006), and NDE (ORNDE = 4.45; 95% CI 1.27, 15.53; p = 0.019) on HCC risk. In addition, a significant NIE mediated through MASLD was observed (ORNIE = 1.34; 95% CI 1.14, 1.57; p < 0.001). Based on the OR scale, the proportion of MTE mediated (PM) through MASLD was 16.4% (PM = 16.4%; 95% CI 14.1%, 35.4%; p = 0.049), suggesting that this proportion of the effect could potentially be prevented through interventions targeting MASLD. Dietary modification, alongside systematic screening and management of MASLD, may help reduce HCC risk. Sensitivity analysis indicated that the relatively small E-value and its lower bound for the NIE suggest that an unmeasured confounder could potentially explain the observed NIE. Prospective studies are therefore warranted to confirm these findings.